Compare LQDA & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | PTRN |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2018 | 2025 |
| Metric | LQDA | PTRN |
|---|---|---|
| Price | $34.21 | $11.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $37.40 | $19.89 |
| AVG Volume (30 Days) | ★ 1.1M | 875.1K |
| Earning Date | 11-03-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $69,216,000.00 | ★ $2,293,676,000.00 |
| Revenue This Year | $994.17 | $39.63 |
| Revenue Next Year | $169.25 | $24.32 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 343.41 | 67.86 |
| 52 Week Low | $11.26 | $11.30 |
| 52 Week High | $36.41 | $20.10 |
| Indicator | LQDA | PTRN |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | N/A |
| Support Level | $33.45 | N/A |
| Resistance Level | $36.60 | N/A |
| Average True Range (ATR) | 1.41 | 0.00 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 47.88 | 0.00 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.